Your browser doesn't support javascript.
Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study.
Kaso, Abdene Weya; Agero, Gebi; Hurissa, Zewdu; Kaso, Taha; Ewune, Helen Ali; Hareru, Habtamu Endashaw; Hailu, Alemayehu.
  • Kaso AW; School of Public Health, College of Medicine and Health Science, Dilla University, Dilla, Ethiopia.
  • Agero G; Department of Public Health, College of Health Science, Arsi University, Assela, Ethiopia.
  • Hurissa Z; Department of Internal Medicine, College of Health Science, Arsi University, Assela, Ethiopia.
  • Kaso T; Department of Surgery, College of Health Science, Arsi University, Assela, Ethiopia.
  • Ewune HA; School of Public Health, College of Medicine and Health Science, Dilla University, Dilla, Ethiopia.
  • Hareru HE; School of Public Health, College of Medicine and Health Science, Dilla University, Dilla, Ethiopia.
  • Hailu A; Bergen Centre for Ethics and Priority Setting, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
PLoS One ; 17(5): e0268280, 2022.
Article in English | MEDLINE | ID: covidwho-1833664
ABSTRACT

BACKGROUND:

COVID-19 is a global public health problem causing high mortality worldwide. This study aimed to assess time to death and predictors of mortality among patients hospitalized for COVID-19 in the Arsi zone treatment center.

METHOD:

We performed a retrospective observational cohort study using medical records of laboratory-confirmed COVID-19 cases hospitalized at Bokoji Hospital COVID-19 treatment center from 1st July 2020 to 5th March 2021. We extracted data on the patients' sociodemographic and clinical characteristics from medical records of hospitalized patients retrospectively. We carried out Kaplan Meier and Cox regression analysis to estimate survival probability and investigate predictors of COVID-19 death 5% level of significance. The Adjusted Hazard Ratio (aHR) with 95% Confidence Interval (CI) was estimated and interpreted for predictors of time to death in the final cox model.

RESULT:

A total of 422 COVID-19 patients treated were analyzed, of these more than one tenth (11.14%) deaths, with a mortality rate of 6.35 cases per 1000 person-days. The majority (87.2%) of deaths occurred within the first 14 days of admission, with a median time-to-death of nine (IQR 8-12) days. We found patients that age between 31 and 45 years (aHR = 2.55; 95% CI (1.03, 6.34), older than 46 years (aHR = 2.59 (1.27, 5.30), chronic obstructive pulmonary disease (aHR = 4.60, 95%CI (2.37, 8.91), Chronic kidney disease (aHR = 5.58, 95%CI (1.70, 18.37), HIV/AIDS (aHR = 3.66, 95%CI (1.20, 11.10), admission to the Intensive care unit(aHR = 7.44, 95%CI (1.82, 30.42), and being on intranasal oxygen care (aHR = 6.27, 95%CI (2.75, 4.30) were independent risk factors increasing risk of death from COVID-19 disease than their counterparts.

CONCLUSION:

The risk of dying due to COVID-19 disease was higher among patients with HIV/AIDS, chronic obstructive pulmonary disease, and chronic kidney diseases. We also found that older people, those admitted to ICU, and patients who received intranasal oxygen care had a higher risk of dying due to COVID-19 disease. Therefore, close monitoring hospitalized patients that are old aged and those with comorbidities after hospitalization is crucial within the first ten days of admission.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acquired Immunodeficiency Syndrome / Pulmonary Disease, Chronic Obstructive / COVID-19 / COVID-19 Drug Treatment Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Africa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0268280

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Acquired Immunodeficiency Syndrome / Pulmonary Disease, Chronic Obstructive / COVID-19 / COVID-19 Drug Treatment Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Africa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0268280